Envirotyping helps in better understanding the root cause of success and limitations of rainfed production systems

The current diagnostic agronomy study of the Bankura region of West Bengal, India, examined the variations in crop yields through a socio-ecological analysis of multiple production system components. Envirotyping for root cause analysis was employed to delve into the variables that affect the performance of rainfed production systems. Mother Earth, man, machine, management, and materials (5Ms concept) were the five indicators under which the variables were grouped. Findings demonstrated the fragility of the region's soils due to its undulating terrain, unpredictable rainfall patterns, and frequent drought scenarios. The LULC's NDVI showed that the agricultural area is about 60% and 43% of the total geographical area in the Hirbandh and Ranibandh blocks, respectively. Soils are acidic and diagnosed with deficiency of both macro and micronutrients (phosphorous, sulfur, and boron) having poor water holding capacity (35 to 55 mm for a 50 cm soil depth). The sand and soil organic carbon contents ranged between 43.04%-82.32% and 0.17%-1.01%, respectively with a low bacterial population. These factors are the root cause for low cropping intensity (106%) and low paddy productivity (3,021 kg/ha). Overall, the study contributes to designing and scaling-up of sustainable landscape management practices that could ensure higher cropping intensity and system productivity in similar agro-ecologies with limited evidence

Optimization for the Production of Surfactin with a New Synergistic Antifungal Activity

-surfactin and the optimization of its production by the response surface method.O. A production of 134.2 mg/L, which were in agreement with the prediction, was observed in a verification experiment. In comparison to the production of original level (88.6 mg/L), a 1.52-fold increase had been obtained.-surfactin

Tuberculosis chemotherapy: current drug delivery approaches

Tuberculosis is a leading killer of young adults worldwide and the global scourge of multi-drug resistant tuberculosis is reaching epidemic proportions. It is endemic in most developing countries and resurgent in developed and developing countries with high rates of human immunodeficiency virus infection. This article reviews the current situation in terms of drug delivery approaches for tuberculosis chemotherapy. A number of novel implant-, microparticulate-, and various other carrier-based drug delivery systems incorporating the principal anti-tuberculosis agents have been fabricated that either target the site of tuberculosis infection or reduce the dosing frequency with the aim of improving patient outcomes. These developments in drug delivery represent attractive options with significant merit, however, there is a requisite to manufacture an oral system, which directly addresses issues of unacceptable rifampicin bioavailability in fixed-dose combinations. This is fostered by the need to deliver medications to patients more efficiently and with fewer side effects, especially in developing countries. The fabrication of a polymeric once-daily oral multiparticulate fixed-dose combination of the principal anti-tuberculosis drugs, which attains segregated delivery of rifampicin and isoniazid for improved rifampicin bioavailability, could be a step in the right direction in addressing issues of treatment failure due to patient non-compliance